Zelluna ASAOSTO:ULTIO 28 Market Cap is kr488.62 Mil as of Jun. 28, 2026. GuruFocus rates OSTO:ULTIO with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 1,431 Biotechnology companies, Zelluna ASA ranks worse than 62.75% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Zelluna ASA's share price for the quarter that ended in Mar. 2026 was kr21.95. Zelluna ASA's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 26.27 Mil. Therefore, Zelluna ASA's market cap for the quarter that ended in Mar. 2026 was kr576.63 Mil.
Zelluna ASA's quarterly market cap
increased
from Sep. 2025 (kr448.97 Mil) to Dec. 2025 (kr576.63 Mil) but then
stayed the same
from Dec. 2025 (kr576.63 Mil) to Mar. 2026 (kr576.63 Mil).
Zelluna ASA's annual market cap
declined
from Dec. 2023 (kr4,163.61 Mil) to Dec. 2024 (kr83.62 Mil) but then
increased
from Dec. 2024 (kr83.62 Mil) to Dec. 2025 (kr576.63 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Zelluna ASA's Enterprise Value for Today is kr439.63 Mil.
Zelluna ASA (OSTO:ULTIo) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Zelluna ASA Market Cap Related Terms
Zelluna ASA Market Cap Historical Data
* Premium members only.
The historical data trend for Zelluna ASA's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ULTIO vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, Zelluna ASA's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zelluna ASA Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zelluna ASA's Market Cap distribution charts can be found below:
* The bar in red indicates where Zelluna ASA's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Zelluna ASA's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zelluna ASA (OSTO:ULTIO) has a Market Cap of kr488.62 Mil as of Jun. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Zelluna ASA and its competitors. According to the industry distribution chart, Zelluna ASA ranks #898 out of 1431 companies in the Biotechnology industry, placing it in the top 62.8%.
Is Zelluna ASA's Market Cap too high?
Zelluna ASA's current Market Cap is kr488.62 Mil. Based on the distribution chart, Zelluna ASA ranks #898 out of 1431 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Zelluna ASA has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Zelluna ASA's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Zelluna ASA ranks #898 out of 1431 companies for Market Cap. This places Zelluna ASA in the lower half of its industry. The industry median Market Cap is 113.83. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 113.83, based on 1,431 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Zelluna ASA and its competitors. For the Biotechnology industry, the median Market Cap is 113.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zelluna ASA's current Market Cap is kr488.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zelluna ASA stock overvalued right now?
Zelluna ASA (OSTO:ULTIO) has a current Market Cap of kr488.62 Mil. The current Market Cap is kr488.62 Mil. Zelluna ASA's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Zelluna ASA (OSTO:ULTIO), the current Market Cap is kr488.62 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zelluna ASA is a biotechnology company established to eliminate solid cancers by unleashing the powerful elements of the immune system through pioneering the development of T cell receptor (TCR) guided natural killer (NK) cell therapies (TCR-NK). Its TCR-NK products are composed of healthy donor-derived NK cells that are genetically engineered to express a tumour-specific TCR that enable the TCR-NK cells to identify and eliminate cancer cells in the body of the patient. Its programme ZI-MA4-1, the first MAGE-A4-targeting TCR-NK therapy for solid tumours with high unmet medical need. Its other programmes include ZI-KL1-1, and ZI-PR-1.
28GF Score
Get the complete analysis for OSTO:ULTIO
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ULTIO has been successfully added to your 
